drugset / Trial / NCT03003143
Effect of Vigabatrin in Refractory Autoimmune Encephalitis Patients
Withdrawn
Seoul National University Hospital
NaSingle-groupOpen-labelTreatment
Summary
Investigation of efficacy of vigabatrin in refractory autoimmune encephalitis patients
Timeline
- Start
- 2016-11
- Primary completion
- 2020-09-09
- Completion
- 2020-09-09
Publications
- Background Bjurstom H, Wang J, Ericsson I, Bengtsson M, Liu Y, Kumar-Mendu S, Issazadeh-Navikas S, Birnir B. GABA, a natural immunomodulator of T lymphocytes. J Neuroimmunol. 2008 Dec 15;205(1-2):44-50. doi: 10.1016/j.jneuroim.2008.08.017. Epub 2008 Oct 26.
- Background Rossi S, Muzio L, De Chiara V, Grasselli G, Musella A, Musumeci G, Mandolesi G, De Ceglia R, Maida S, Biffi E, Pedrocchi A, Menegon A, Bernardi G, Furlan R, Martino G, Centonze D. Impaired striatal GABA transmission in experimental autoimmune encephalomyelitis. Brain Behav Immun. 2011 Jul;25(5):947-56. doi: 10.1016/j.bbi.2010.10.004. Epub 2010 Oct 20.
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Vigabatrin | Small molecule | 500 mg | — |